Glaucoma Therapeutics Global Market Report 2022: Development of Innovative Combination Drugs Sparks Sector Growth – ResearchAndMarkets.com

November 23, 2022 Off By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Glaucoma Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering.

The global glaucoma therapeutics market size reached US$ 7 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 10.2 Billion by 2027, exhibiting a CAGR of 6.48% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The increasing prevalence of glaucoma across the globe represents one of the key factors driving the growth of the market. Glaucoma is highly prevalent in patients with diabetes and other eye disorders, such as age-related macular degeneration (AMD), cataract and dry eye.

In line with this, the rising geriatric population, which is more susceptible to such ailments, is creating a positive outlook for the market growth. Furthermore, increasing health consciousness among the masses and rising preference for laser glaucoma surgery is also driving the market growth.

Additionally, the development of innovative combination drugs is acting as another growth-inducing factor. Pharmaceutical manufacturers are creating anti-glaucoma drugs and prostaglandin analogs combined with two or more drugs to control the elevated levels of IOP. Other factors, including the advent of advanced glaucoma diagnostic techniques, along with improvements in the healthcare infrastructure, are anticipated to drive the market further.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global glaucoma therapeutics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on drug class, indication and end user.

Breakup by Drug Class:

  • Prostaglandin Analogs
  • Beta Blockers
  • Alpha Adrenergic Agonists
  • Carbonic Anhydrase Inhibitors
  • Combination Drugs
  • Others

Breakup by Indication:

  • Open Angle Glaucoma
  • Angle Closure Glaucoma
  • Others

Breakup by End User:

  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgery Centers
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Glaucoma Therapeutics Market

6 Market Breakup by Drug Class

7 Market Breakup by Indication

8 Market Breakup by End User

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape

Companies Mentioned

  • Aerie Pharmaceuticals Inc.
  • Allergan Plc
  • Bausch & Lomb Incorporated (Bausch Health Companies Inc.)
  • Inotek Pharmaceuticals Corp.
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Santen Pharmaceutical Co. Ltd.
  • SIFI S.p.A
  • Teva Pharmaceutical Industries Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/h57pzq

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900